Log In
Print this Print this

DuoCort, Plenadren (hydrocortisone tablet)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionOnce-daily dual-release hydrocortisone tablet
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAdrenal insufficiency
Indication DetailsTreat Addison's disease; Treat adrenal insufficiency
Regulatory Designation U.S. - Orphan Drug (Treat adrenal insufficiency);
EU - Orphan Drug (Treat adrenal insufficiency);
Switzerland - Orphan Drug (Treat Addison's disease)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today